Data protection Impressum

Financing

Biotech Vandria has raised an additional CHF 14 million to accelerate the development of innovative treatments for age-related and chronic diseases, bringing its total Series A financing to CHF 28.3 million.

Vandria secures over CHF 14 million to advance age-related disease therapies

3 September 2024

Four pioneering Geneva-based start-ups have received funding from the FONGIT Innovation Fund (FIF) to drive innovation in the life sciences and ICT sectors.

FONGIT Innovation Fund finances four ICT and life sciences start-ups from Geneva

2 September 2024

Top Stories Western Switzerland

Top Stories from Western Switzerland (August 2024)

30 August 2024

GraphEnergyTech, a Lausanne-based start-up with offices in Cambridge, UK, has raised CHF 1.1 million in funding to accelerate the development and scaling of its advanced graphene electrodes for solar cells.

GraphEnergyTech secures CHF 1.1 million to advance graphene solar cell technology

19 August 2024

Relief Therapeutics has entered into an agreement with SWK Funding LLC to secure up to USD 11 million in non-dilutive financing through the sale of royalty interests to support its clinical development pipeline.

Geneva biotech Relief Therapeutics raises up to USD 11 million from royalty sales

14 August 2024

SWISSto12, an EPFL spin-off and leader in satellite and Radio Frequency (RF) products, has secured a USD 10 million contract to supply next-generation RF equipment to a European aeronautical OEM, enhancing safety at sea.

SWISSto12 secures USD 10 million contract for maritime safety technology

13 August 2024

DemoSquare has successfully raised CHF 1.2 million in pre-seed funding to fuel its expansion into European markets, aiming to enhance its AI-based platform for monitoring political and regulatory activities.

DemoSquare secures CHF 1.2 million for the expansion of its AI-based platform

13 August 2024

Release Therapeutics has raised CHF 3.3 million in seed funding to advance its innovative approach to treating metachromatic leukodystrophy (MLD), a rare genetic disorder affecting young children.

Release Therapeutics secures CHF 3.3 million to advance MLD research

13 August 2024

Oryl Photonics has joined the Fast and Accurate Solubility for Sustainability (FASS) project, receiving a EUR 2.5 million EIC Transition grant to develop a novel laboratory instrument for drug solubility measurement.

EPFL spin-off Oryl Photonics joins a EUR 2.5 million European project

7 August 2024

Geneva-based Agora Care has closed a financing round of CHF 2.2 million to support its expansion into the US market and increase patient enrollment in Switzerland and Europe.

Medical imaging specialist Agora Care secures CHF 2.2 million for US market expansion

5 August 2024

1 … 5 6 7 8 9 10 11 12 13 … 32